MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 142 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,653,000 | -60.9% | 1,333,311 | -3.0% | 0.00% | -50.0% |
| Q1 2017 | $4,233,000 | +11.6% | 1,374,195 | +47.8% | 0.00% | 0.0% |
| Q4 2016 | $3,794,000 | -9.8% | 929,954 | +34.1% | 0.00% | 0.0% |
| Q3 2016 | $4,207,000 | +48.0% | 693,611 | +31.5% | 0.00% | +100.0% |
| Q2 2016 | $2,842,000 | -35.6% | 527,326 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $4,414,000 | -13.2% | 527,326 | -18.1% | 0.00% | -33.3% |
| Q4 2015 | $5,087,000 | +40.6% | 643,876 | +51.5% | 0.00% | +50.0% |
| Q3 2015 | $3,618,000 | – | 425,107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 2,211,880 | $17,474,000 | 4.63% |
| Parametrica Management Ltd | 21,228 | $168,000 | 1.11% |
| GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $653,000 | 0.73% |
| Virtus ETF Advisers LLC | 33,570 | $265,000 | 0.73% |
| Opus Point Partners Management, LLC | 122,500 | $968,000 | 0.64% |
| NEXTHERA CAPITAL LP | 36,000 | $284,000 | 0.40% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 7,255,815 | $57,321,000 | 0.39% |
| Cannell & Co. | 1,051,178 | $7,751,000 | 0.25% |
| Tekla Capital Management LLC | 853,787 | $6,745,000 | 0.24% |
| STONERIDGE INVESTMENT PARTNERS LLC | 208,282 | $1,645,000 | 0.22% |